Abstract:Objective: To evaluate the impact of number-indexes of lymph nodes for prognostic stratification in stage N1c colorectal cancer (CRC) patients. Methods: The clinicopathologic data of CRC patients with stage pTxN1cM0 who initially underwent radical surgery in Cancer Hospital, Chinese Academy of Medical Sciences and the Surveillance, Epidemiology and End Results (SEER) database from January 2010 to December 2015 were retrospectively analyzed. A total of 1 165 patients with stage N1c were included in this study. Among them, 85 patients (including 54 males and 31 females) were from Cancer Hospital, Chinese Academy of Medical Sciences and their median age was 58 (range: 32-80) years; 1 080 patients (including 566 males and 514 females) were from the SEER database and their median age was 66 (range: 24-98) years. The prognostic significance of total number of lymph node (TLN), number of negative lymph node (NLN), and log odds of positive lymph nodes (LODDS) in stage N1c CRC patients were explored. Results: The optimal cut-off value of TLN or NLN was 13, and the optimal cut-off value of LODDS was -1.43. Among the 85 patients of Cancer Hospital, Chinese Academy of Medical Sciences, the 5-year overall survival (OS) rates of stage N1c1 (TLN or NLN≥13, 69 cases) and group LODDS1 patients (LODDS≤-1.43, 69 cases) were both 80.9%, which higher than that of stage N1c2 (TLN or NLN<13, 16 cases) and group LODDS2 (LODDS>-1.43, 16 cases) patients (both 53.3%, P=0.002); In the SEER cohort, the 5-year OS rates of stage N1c1 (837 cases) and group LODDS1 patients (LODDS≤-1.43, 837 cases) were both 64.7%, which higher than that of stage N1c2 (243 cases) and group LODDS2 (LODDS>-1.43, 243 cases) patients (both 52.2%, P<0.001). Both in the NCC cohort and SEER cohort, the results of Cox multivariate analysis all demonstrated that TLN or NLN<13 was the risk factor of OS of CRC patients with stage N1c (HR=3.794, 95%CI: 1.539-9.349, P=0.004; and HR=1.588, 95%CI:1.232-2.048, P<0.001; respectively); LODDS≤-1.43 was the independent protective factor of OS of stage N1c CRC patients (HR=0.264, 95%CI: 0.107-0.650; and HR=0.630, 95%CI: 0.488-0.812; respectively). Conclusions: TLN or NLN and LODDS were all independent prognostic factors of CRC patients with stage N1c. The clinicians could use TLN or NLN and LODDS for prognostic stratification and make the different adjuvant therapeutic schemes for CRC patients with stage N1c.

Prognostic Value of Negative Lymph Node Count in Patients with Jejunoileal Neuroendocrine Tumors

The Lymph node ratio optimizes staging in patients with small intestinal neuroendocrine tumors.

Negative lymph node count is an independent prognostic factor for patients with rectal cancer who received preoperative radiotherapy

Increased number of negative lymph nodes is associated with improved survival outcome in node positive gastric cancer following radical gastrectomy.

Impact of examined lymph node count on prognosis in patients with lymph node-negative pancreatic body/tail ductal adenocarcinoma.

Number of Positive Lymph Nodes is Superior to LNR and LODDS for Predicting the Prognosis of Pancreatic Neuroendocrine Neoplasms

Clinicopathological Features And Prognostic Factors Of Colorectal Neuroendocrine Neoplasms

Examined Lymph Node Numbers Influence Prognosis in Rectal Cancer Treated with Neoadjuvant Therapy

The Value of Lymph Node Ratio in the Prediction of Rectal Cancer Patient Survival after Preoperative Chemoradiotherapy.

Prognostic Value of Lymph Node Status and Lymphadenectomy in Pancreatic Neuroendocrine Tumors

Number of negative lymph nodes with a positive impact on survival of stage III colon cancer; a retrospective observation study for right side and left side colon

Increased Number of Negative Lymph Nodes is Associated with Improved Cancer Specific Survival in Pathological Iiib and Iiic Rectal Cancer Treated with Preoperative Radiotherapy

Number of negative lymph nodes is associated with disease-free survival in patients with breast cancer

Prognostic Value of Lymph Node Positivity and Number of Lymph Nodes Required for Accurate Staging of Pancreatic Neuroendocrine Tumors.

Prognostic value of the number of negative lymph nodes in non-small cell lung cancer without lymphatic metastasis after pulmonary resection

Prognostic significance of negative lymph node count in microsatellite instability-high colorectal cancer

Prognostic Value and Clinical Predictors of Lymph Node Metastases in Pancreatic Neuroendocrine Tumors

Effect of Lymph Nodes Count in Node-Positive Gastric Cancer

[The prognostic impact of number-indexes of lymph nodes in stage N1c colorectal cancer patients]

Number of Negative Lymph Nodes As a Prognostic Factor for Ypn0-N1 Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy

Preoperative Neutrophil-to-lymphocyte Ratio and Tumor-Related Factors to Predict Lymph Node Metastasis in Nonfunctioning Pancreatic Neuroendocrine Tumors.